6533b7d8fe1ef96bd126afbb

RESEARCH PRODUCT

Low-Frequency Electrical Stimulation Increases Muscle Strength and Improves Blood Supply in Patients With Chronic Heart Failure

Jean Christophe EicherPetr DobšákJean Eric WolfTomoyuki YambeKou ImachiJiří VítovecJarmila SiegelováMakoto NagasakaBohumil FišerMarie NovákováMasahiro KohzukiShin-ichi Nitta

subject

Malemedicine.medical_specialtyStimulation030204 cardiovascular system & hematologyVentricular Function LeftBody Mass Index03 medical and health sciences0302 clinical medicineCoronary CirculationInternal medicineHumansMedicineIn patientMuscle SkeletalHeart FailureVentricular functionbusiness.industryHeartGeneral MedicineBlood flowMiddle Agedmedicine.diseaseElectric StimulationC-Reactive ProteinChronic diseaseHeart failureChronic DiseaseCardiologyMuscle strengthFemaleBlood supplyShear StrengthCardiology and Cardiovascular MedicinebusinessBiomarkersBlood Flow Velocity030217 neurology & neurosurgery

description

This study was designed to evaluate the effects of low-frequency electrical stimulation (LFES) on muscle strength and blood flow in patients with advanced chronic heart failure (CHF).Patients with CHF (n=15; age 56.5 +/- 5.2 years; New York Heart Association III - IV; ejection fraction 18.7 +/- 3.3%) were examined before and after 6 weeks of LFES (10 Hz) of the quadriceps and calf muscles of both legs (1 h/day, 7 days/week). Dynamometry was performed weekly to determine maximal muscle strength (F(max); N) and isokinetic peak torque (PT(max); Nm); blood flow velocity (BFV) was measured at baseline and after 6 weeks of LFES using pulsed-wave Doppler velocimetry of the right femoral artery. Six weeks of LFES significantly increased F(max) (from 224.5 +/- 96.8 N to 340.0 +/- 99.4 N; p0.001), and also PT(max) (from 94.5 +/- 41.5 Nm to 135.3 +/- 28.8 Nm; p0.01). BFV in the femoral artery increased after 6 weeks from 35.7 +/- 15.4 cm/s to 48.2 +/- 18.1 cm/s (p0.05); BFV values at rest before and after 6 weeks of LFES did not differ significantly.LFES may improve muscle strength and blood supply, and could be recommended for the treatment of patients with severe CHF.

https://doi.org/10.1253/circj.70.75